Expertise in
2
conditions

Andrew D. Chantry

Sheffield, ENG, GB 
Expertise in
2
conditions
Sheffield, ENG, GB 

Overview

Andrew Chantry practices practicing medicine in Sheffield, United Kingdom.

Chantry is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Multiple Myeloma, Stiff Person Syndrome, Osteolysis Syndrome Recessive, Bone Marrow Transplant, and Vertebroplasty.

They are actively involved in clinical research, co-authoring 66 peer reviewed articles and participating in 4 clinical trials.

Locations

Sheffield, ENG, United Kingdom
Other Locations
Norwich, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Untreated Transplant-eligible Patients with Symptomatic MM to Evaluate the Benefit of Upfront ASCT
Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Untreated Transplant-eligible Patients with Symptomatic MM to Evaluate the Benefit of Upfront ASCT
Enrollment Status: Active_not_recruiting
Publish Date: December 06, 2024
Intervention Type: Procedure, Drug
Study Drug: Consolidation with 4 cycles of CarCyDex
Study Phase: Phase 2
A Single Arm Open Labeled Multicentre Phase 1b Dose Escalation Study of Carfilzomib Taken in Combination With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
A Single Arm Open Labeled Multicentre Phase 1b Dose Escalation Study of Carfilzomib Taken in Combination With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
Enrollment Status: Completed
Publish Date: April 15, 2021
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
VIRel: Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma - A Phase I Study to Assess the Safety and Tolerability of REOLYSIN® (Pelareorep) in Combination With Lenalidomide or Pomalidomide
VIRel: Viral Immunotherapy in Relapsed/Refractory Multiple Myeloma - A Phase I Study to Assess the Safety and Tolerability of REOLYSIN® (Pelareorep) in Combination With Lenalidomide or Pomalidomide
Enrollment Status: Unknown
Publish Date: January 22, 2020
Intervention Type: Drug, Biological
Study Drugs: Lenalidomide or Pomalidomide, REOLYSIN
Study Phase: Phase 1
A Phase I Open-Label Dose Escalation Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care Chemotherapy for the Treatment of Multiple Myeloma
A Phase I Open-Label Dose Escalation Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care Chemotherapy for the Treatment of Multiple Myeloma
Enrollment Status: Completed
Publish Date: July 10, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 3 Less Clinical Trials

66 Total Publications

An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacy.
An oncolytic adenovirus targeting SLAMF7 demonstrates anti-myeloma efficacy.
Journal: Leukemia
Published: September 17, 2024

Frequently Asked Questions about Andrew D. Chantry

Is Andrew D. Chantry a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Andrew D. Chantry is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andrew D. Chantry participate in research or clinical trials?

Yes. Andrew D. Chantry has published 66 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Andrew D. Chantry's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chantry's expertise for a condition
ConditionClose
      View All 7 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile